SCHEMBL20186647

SCHEMBL20186647

C#CCCC1c2c(c3cc(Cl)ccc3n2[Si](C)(C)C(C)(C)C)CCN1S(=O)(=O)c1ccc(F)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR6 P50406 8/20 0.37
▸ PSEN1 P49768 1/20 0.32
▸ PSEN2 P49810 1/20 0.32
▸ APH1B Q8WW43 1/20 0.32
▸ NCSTN Q92542 1/20 0.32
▸ APH1A Q96BI3 1/20 0.32
▸ PSENEN Q9NZ42 1/20 0.32
▸ HTR7 P34969 1/20 0.31
▸ MAPT P10636 3/20 0.31
▸ THRB P10828 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ KDM4E B2RXH2 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ GAA P10253 1/20 0.31
▸ PTGDR2 Q9Y5Y4 2/20 0.31
▸ TBXA2R P21731 1/20 0.31
▸ PTGDR Q13258 1/20 0.31
▸ HTR5A P47898 1/20 0.31
▸ KCNH2 Q12809 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20186692 0.91 HSD11B1 (0.34) HTR6PSEN1PSEN2APH1BNCSTN
SCHEMBL20186463 0.87 HTR6 (0.36) HTR6PSEN1PSEN2APH1BNCSTN
SCHEMBL20186810 0.80 AKR1B10 (0.33) MAPTKDM4EALDH1A1LMNAGAA
SCHEMBL20186640 0.79 NOD1 (0.36) MAPTSMN1; SMN2ALDH1A1LMNAHTR5A
SCHEMBL20186663 0.69 ABCG2 (0.41) SMN1; SMN2ALDH1A1LMNATBXA2RPTGDR
SCHEMBL18201257 0.68 ABCB1 (0.35) KDM4E
SCHEMBL13654432 0.58 KCNH2 (0.43) MAPTKDM4EALDH1A1LMNAGAA
SCHEMBL834050 0.58 HTR6 (0.84) HTR6
SCHEMBL1120720 0.57 HTR5A (0.40) HTR6MAPTKDM4EALDH1A1LMNA
SCHEMBL13654635 0.57 KCNH2 (0.38) MAPTKDM4EALDH1A1LMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3288921-B1 POLYCYCLIC INDOLINE AND INDOLENINE COMPOUNDS UNIV COLORADO REGENTS (US) 2022-06-15 — — EP disclosed
US-10253024-B2 Polycyclic indoline and indolenine compounds THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) 2019-04-09 — — US disclosed
US-20180148442-A1 Polycyclic Indoline and Indolenine Compounds THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) 2018-05-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10253024-B2 Polycyclic indoline and indolenine compounds IDO1, IDO2, INMT HTR6 827/4885PSEN1 755/4885PSEN2 1498/4885
US-20180148442-A1 Polycyclic Indoline and Indolenine Compounds IDO1, IDO2, INMT HTR6 827/4885PSEN1 755/4885PSEN2 1498/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback